The need for novel coronavirus testing is great in the United States, and the government is responding by encouraging diagnostic companies to develop tests under the FDA’s Emergency Use Authorization (EUA) process.
GenMark Diagnostics Inc. submitted an EUA to the FDA for its ePlex SARS-CoV-2 test, which tests for the novel coronavirus that causes COVID-19, and is expecting to receive a response quickly. Test results would be available in less than two hours.
The ePlex SARS-CoV-2